Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 06, 2023

BUY
$63.71 - $70.74 $199,603 - $221,628
3,133 New
3,133 $200,000
Q2 2022

Jul 11, 2022

BUY
$72.62 - $79.98 $191,644 - $211,067
2,639 New
2,639 $203,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Capital Market Strategies LLC Portfolio

Follow Capital Market Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Market Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Market Strategies LLC with notifications on news.